Giulia Freer

6PUBLICATIONS
32CO-AUTHORS
Biologically active moleculesMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 23, 2026
Development of N-Hydroxyindole-2-Carboxamides as New Host-Targeted Broad-Spectrum Antiviral Agents Against Human Respiratory Viruses.

|Oct 29, 2025
Arylpiperazinyl-Benzocycloheptapyrrole-Carboxamides Endowed with Dual Anticancer and Antiviral Activities.

Gabriele Murineddu, Carlo Di Marzo, Paola Corona

|Sep 18, 2025
A Pyrido-Quinoxaline Derivative That Downregulates Reticulon 3 Protein Exhibits Potent Antiviral Activity Against Zika Virus.

Erika Plicanti, Andrea Deiana, Silvia Nottoli

|Jun 27, 2025
Nasal Emulgel's Role in Preventing Coronavirus Infection.

Francesca Accioni, Giovanna Rassu, Antonio Brunetti

|Apr 29, 2023
Canonical fibroblast growth factors in viral infection.

Giulia Lottini, Erika Plicanti, Michele Lai

|Jan 04, 2017
Evaluation of T Cell Immunity against Human Cytomegalovirus: Impact on Patient Management and Risk Assessment of Vertical Transmission.

Giulia Freer, Paola Quaranta, Mauro Pistello

Pageof 1

Frequent Collaborators

5 joint publications

Erika Plicanti

1 joint publications

Giulia Lottini

1 joint publications

Francesca Accioni

1 joint publications

Giovanna Rassu